Does vitamin D deficiency impair immune regulation and increase respiratory infection risk?

Vitamin D functions as a potent immunomodulator, and its deficiency is strongly linked to both dysfunctional immune signaling and an increased vulnerability to respiratory illnesses. The Vitamin D Receptor (VDR) is present on nearly all immune cells, meaning that insufficient serum levels (typically defined as <50 nmol/L or 20 ng/mL) disrupt the transcriptional regulation of over 200 genes essential for immune homeostasis.

Mechanistic impact on innate and adaptive immunity

Vitamin D deficiency impairs the body's primary defenses and its long-term immune memory through several pathways:

• Innate Immunity: Deficiency compromises the production of antimicrobial peptides, such as cathelicidin (LL-37) and defensins, which are critical for neutralizing pathogens at mucosal surfaces. It also prevents macrophages from transitioning to an anti-inflammatory "M2" state, instead favoring a pro-inflammatory "M1" phenotype that increases the production of cytokines like TNF-α and IL-1β.
• Adaptive Immunity: Low vitamin D levels hinder the development of T-regulatory (T-reg) cells, which are responsible for maintaining immune tolerance. This loss of regulation leads to an over-activation of Th1 and Th17 cells, resulting in elevated IL-17 levels and a shift toward chronic inflammation and autoimmunity.

Clinical evidence for respiratory infections

The clinical consequences of these impairments are well-documented in large-scale studies:

• Infection Risk: Meta-analyses involving nearly 10,000 patients indicate that vitamin D deficiency is associated with a significantly higher risk of respiratory infections (Relative Risk 1.49) and sepsis (RR 1.46).
• Viral Susceptibility: Individuals with serum levels below 38 ng/mL have shown a two-fold increase in acute viral respiratory tract infections compared to those with higher levels.
• Impact of Correction: Clinical trials demonstrate that the protective effect of vitamin D is most pronounced when supplementing those with severe deficiency (<25 nmol/L). Daily or weekly dosing in these populations has been shown to reduce infection risk with an odds ratio of approximately 0.81.

Bottom line

Vitamin D deficiency is a scientifically supported driver of immune dysregulation and increased susceptibility to respiratory infections. Correcting a deficiency is essential for restoring innate antimicrobial defenses and maintaining adaptive immune tolerance, particularly for those with serum levels below 25-50 nmol/L.